What does CUSIP 74365U107 represent in this 13F holders report?

CUSIP 74365U107 is the security identifier for TARA - Protara Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TARA - Protara Therapeutics, Inc. - Common Stock in Q3 2023?

31 institutional investors reported TARA - Protara Therapeutics, Inc. - Common Stock for Q3 2023. Use the holders table for investor-level position and value details.

Protara Therapeutics, Inc. - Common Stock (TARA)

CUSIP: 74365U107

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / Common Stock
Total 13F shares: 5,117,943
Total 13F value: $8,547,441
Share change: -18,594
SEC-reported price per share: $1.67
Number of holders: 31
Value change: -$31,849
Number of buys: 7
Number of sells: 10
Shares outstanding: 55,913,202

Security key

74365U107

Report period

Q3 2023

Institutions

Top holders

TARA full security history Ownership snapshot Full 13F holder table Protara Therapeutics, Inc. SEC filings Protara Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TARA - Protara Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Opaleye Management Inc.

Disclosed value leader

Opaleye Management Inc.

Comparable rows

15/15

Latest evidence

30 Jun 2023

13F Lead comparable stake: 4.8% Showing 1-6 of 15 holder rows.

Quick read

Opaleye Management Inc. leads the comparable SEC ownership view at 4.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Opaleye Management Inc.'s linked filing trail.

Comparable ownership Top 5

Opaleye Management Inc. 4.8%

ORBIMED ADVISORS LLC 1.4%

VANGUARD GROUP INC 0.76%

Boxer Capital, LLC 0.37%

BAKER BROS. ADVISORS LP 0.36%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Opaleye Management Inc.	13F Company 13F	4.8%	$6,435,300 2,692,594 shares	—	30 Jun 2023
ORBIMED ADVISORS LLC	13F Company 13F	1.4%	$1,846,476 772,584 shares	—	30 Jun 2023
VANGUARD GROUP INC	13F Company 13F	0.76%	$1,021,993 427,612 shares	—	30 Jun 2023
Boxer Capital, LLC	13F Company 13F	0.37%	$500,000 209,227 shares	—	30 Jun 2023
BAKER BROS. ADVISORS LP	13F Company 13F	0.36%	$477,214 199,671 shares	—	30 Jun 2023
Ikarian Capital, LLC	13F Company 13F	0.34%	$450,907 188,664 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

5,117,943

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %